Por: ABC News World January 09, 2023
TAIPEI, Taiwan -- China's authorities declined to include Pfizer's COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive. Paxlovid, an oral medicine developed by New York-based drugmaker Pfizer, has been widely sought after in since the country began phasing out its “zero-COVID” restrictions and a surge of infections... + full article
CNBC USA Health December 30, 2022
A new antiviral pill for Covid was found to be as effective as Paxlovid at curbing mild to moderate illness among people at high risk of severe disease in a Phase 3 trial in China.The results, , suggest that the treatment had fewer side effects than Paxlovid, the go-to... + más
Covid-19 treatment Paxlovid can interact with common heart medications, doctors warn | CNN
For some COVID patients, 'Paxlovid rebound' has nothing to do with Paxlovid | Los Angeles Times
Time USA Health November 30, 2022
Months after catching COVID-19 in December 2021, Lavanya Visvabharathy was still and suffering from symptoms including headaches and intense fatigue. So Visvabharathy, a research assistant professor of neurology at the Northwestern University Feinberg School of Medicine who has... + más
Los Angeles Times USA Science November 14, 2022
This is a story about a COVID-19 medication, a nasty trick the coronavirus sometimes plays on its victims, and how the two became a pandemic couple called “Paxlovid rebound.” It's also a story about how looks can be deceiving. Americans have been quick to embrace the... + más
Paxlovid rebound more common than initially thought, doctors say | ABC News
ABC News USA Health November 10, 2022
Six months ago, Dr. Joseph Boselli said he was prescribing the antiviral drug Paxlovid to nearly everyone who turned up at his practice with COVID.Now, the internal medicine physician at Jefferson Health in Philadelphia said he's reserving it mostly for people who are... + más
CNN USA Health November 07, 2022
CNN — Paxlovid, the antiviral pill that reduces the risk of hospitalization and death from Covid-19, also reduces the risk of long Covid, according to a by researchers at the US Department of Veterans Affairs. The study, posted online as a preprint on Saturday, analyzed... + más
There's a growing dementia crisis in the veteran community: Alzheimer's Q&A | The Advocate
CNBC USA Health November 02, 2022
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021.John Thys AFP Getty Images... + más
Pfizer raises 2022 earnings guidance, beats third-quarter expectations | CNBC
Pfizer climbs on strong Q3 results, raised outlook | MarketWatch
CNN USA Health October 14, 2022
CNN — Covid-19 patients with a history of cardiovascular disease are at an increased risk of developing severe illness and could benefit most from the Covid-19 treatment Paxlovid – but there’s a catch. Paxlovid can have dangerous interactions with some of the most... + más
Pfizer pledges $120M to produce oral COVID-19 treatment Paxlovid at Michigan factory | New York Daily News
Study finds Paxlovid can interact badly with some heart medications, and White House renews COVID emergency through Jan. 11 | MarketWatch
About iurex | Privacy Policy | Disclaimer |